Coherus Announces U.S. FDA Approval of YUSIMRY™ (adalimumab-aqvh)
20 déc. 2021 07h59 HE
|
Coherus BioSciences, Inc.
- Approved for all eligible indications of the reference biological product, Humira® (adalimumab) - - YUSIMRY is Coherus' second FDA-approved product - REDWOOD CITY, Calif., Dec. 20, 2021 (GLOBE...
Exagen Inc. Reports Third Quarter 2021 Results
10 nov. 2021 16h05 HE
|
Exagen Inc.
SAN DIEGO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2021....
SetPoint Medical Appoints Amy Derosier as Vice President of Clinical Affairs
03 nov. 2021 09h00 HE
|
SetPoint Medical
VALENCIA, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapies for chronic autoimmune diseases, today announced the...
Trellis Rx Furthers Commitment to Advancing the Specialty Pharmacy Practice and Patient Outcomes with Integration of Scipher Medicine® PrismRA® Precision-Medicine Technology into Clinical Pathways
12 oct. 2021 08h00 HE
|
Scipher Medicine Corporation
ATLANTA and WALTHAM, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Trellis Rx, a leading technology-enabled specialty pharmacy services provider, today announced the integration of PrismRA®, a diagnostic...
UPDATE - Scipher Medicine Welcomes Sam Davis as General Counsel
24 sept. 2021 12h00 HE
|
Scipher Medicine Corporation
WALTHAM, Mass., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announced the appointment of Sam A....
Scipher Medicine Welcomes Sam Davis as General Counsel
24 sept. 2021 09h00 HE
|
Scipher Medicine Corporation
WALTHAM, Mass., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announced the appointment of Sam A....
Scipher Medicine Welcomes John Strumbos as Chief Financial Officer
22 sept. 2021 10h50 HE
|
Scipher Medicine Corporation
WALTHAM, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announced the appointment of John...
Scipher Medicine Welcomes Chip Parkinson as Chief Commercial Officer of its Diagnostics Business
20 sept. 2021 11h11 HE
|
Scipher Medicine Corporation
WALTHAM, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with the most effective therapy, today announces the addition of Chip Parkinson...
Exagen Inc. to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
13 sept. 2021 16h15 HE
|
Exagen Inc.
SAN DIEGO, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Cantor Fitzgerald Virtual Global...
Sorrento Publishes Positive Initial Results of SOFUSA® Lymphatic Drug Delivery System in a Phase 1b Rheumatoid Arthritis Study Using Enbrel
23 août 2021 15h52 HE
|
Sorrento Therapeutics, Inc.
Rheumatoid Arthritis (RA) is one of many chronic autoimmune conditions affecting over 20 million people in the United States (NIH, 2017).Sofusa is a revolutionary technology which delivers biologic...